epilepsy

rocket ship blast off fire away take off
Biotech

Rapport's seizure drug hits in phase 2, sending stock soaring

Based on the data, Rapport plans to start two phase 3 trials of RAP-219 in the third quarter of 2026.
Nick Paul Taylor Sep 8, 2025 8:25am
jazz musicians band music saxophone

Jazz pays Saniona $42.5M to add prospect to epilepsy ensemble

Aug 20, 2025 9:13am
scissor cutting rope

J&J calls time on Addex partnership a year after epilepsy fail

Apr 17, 2025 7:05am
Person lacing up running shoe

Atalanta’s RNA epilepsy asset suppresses seizures in mice

Apr 10, 2025 5:30am
dollar sign with colored arrows in a maze

Cell therapy biotech bags $102M to fund phase 3 epilepsy plans

Apr 3, 2025 1:22pm
workers

Encoded lays off 29% of staff to fund Dravet gene therapy trial

Feb 13, 2025 10:20am